JP7556882B2 - 速崩壊カンナビノイド錠剤 - Google Patents
速崩壊カンナビノイド錠剤 Download PDFInfo
- Publication number
- JP7556882B2 JP7556882B2 JP2021561780A JP2021561780A JP7556882B2 JP 7556882 B2 JP7556882 B2 JP 7556882B2 JP 2021561780 A JP2021561780 A JP 2021561780A JP 2021561780 A JP2021561780 A JP 2021561780A JP 7556882 B2 JP7556882 B2 JP 7556882B2
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- cannabinoids
- cannabinoid
- composition
- module
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3040532 | 2019-04-17 | ||
| CA3040513A CA3040513C (en) | 2019-04-17 | 2019-04-17 | An oral cannabinoid tablet |
| US16/386,477 US10925853B2 (en) | 2019-04-17 | 2019-04-17 | Oral cannabinoid tablet |
| CA3040532A CA3040532C (en) | 2019-04-17 | 2019-04-17 | Lozenge for improved delivery of cannabinoids |
| CA3040547 | 2019-04-17 | ||
| US16/386,477 | 2019-04-17 | ||
| CA3040547A CA3040547C (en) | 2019-04-17 | 2019-04-17 | Cannabinoid lozenge formulation |
| CA3040513 | 2019-04-17 | ||
| CA3065042 | 2019-12-13 | ||
| US16/713,580 US11633351B2 (en) | 2019-12-13 | 2019-12-13 | Fast disintegrating cannabinoid tablets |
| CA3065042A CA3065042C (en) | 2019-12-13 | 2019-12-13 | Fast disintegrating cannabinoid tablets |
| US16/713,580 | 2019-12-13 | ||
| PCT/DK2020/050102 WO2020211915A1 (en) | 2019-04-17 | 2020-04-17 | Fast disintegrating cannabinoid tablets |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529037A JP2022529037A (ja) | 2022-06-16 |
| JP2022529037A5 JP2022529037A5 (cg-RX-API-DMAC10.html) | 2023-04-24 |
| JP7556882B2 true JP7556882B2 (ja) | 2024-09-26 |
Family
ID=70802555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021561780A Active JP7556882B2 (ja) | 2019-04-17 | 2020-04-17 | 速崩壊カンナビノイド錠剤 |
Country Status (12)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020412501A1 (en) * | 2019-12-24 | 2022-08-18 | Cannadol Pharmaceuticals Ltd | Compositions comprising terpenes and their use in the treatment or alleviation of pain or anxiety |
| TWI923583B (zh) * | 2020-04-14 | 2026-05-01 | 美商健生生物科技公司 | 包含胺基嘧啶衍生物或其醫藥上可接受之鹽之用於經口投予之醫藥組成物 |
| LT4243797T (lt) * | 2020-11-16 | 2026-06-10 | Orcosa Inc. | Greitos infuzijos platforma ir kompozicijos, skirtos žmonių terapiniam gydymui |
| US11672761B2 (en) * | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| CN114748429A (zh) * | 2020-12-29 | 2022-07-15 | 汉义生物科技(北京)有限公司 | 一种水溶性大麻素制剂及其制备方法 |
| JP2023010677A (ja) * | 2021-07-09 | 2023-01-20 | 株式会社東洋新薬 | 固形組成物 |
| JP2023010676A (ja) * | 2021-07-09 | 2023-01-20 | 株式会社東洋新薬 | 固形組成物 |
| US20240415853A1 (en) * | 2023-03-21 | 2024-12-19 | Fertin Pharma A/S | Cannabinoid Self-Emulsifying Systems |
| JP2025529608A (ja) * | 2023-07-24 | 2025-09-09 | ポビバ コーポレーション | てんかんを処置する為の組成物及び方法 |
| DK202330231A1 (en) * | 2023-09-27 | 2025-04-10 | Fertin Pharma As | Cannabidiol for alleviating xerostomia |
| CN118021744A (zh) * | 2024-02-05 | 2024-05-14 | 谛邈生物科技(北京)有限公司 | 一种大麻二酚型大麻素化合物冻干闪释片及其制备方法 |
| DK202430722A1 (en) * | 2024-11-25 | 2026-06-09 | Fertin Pharma As | Sugar free soft chew tablets |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005512943A (ja) | 2001-02-14 | 2005-05-12 | ジーダブリュー ファーマ リミテッド | 医薬製剤 |
| JP2007504207A (ja) | 2003-09-05 | 2007-03-01 | アロー・ナンバー7・リミテッド | 口腔内ドラッグ・デリバリー |
| JP2010532367A (ja) | 2007-06-29 | 2010-10-07 | マクニール−ピーピーシー・インコーポレーテツド | 2部分からなるロゼンジ剤形 |
| US20110097283A1 (en) | 2008-03-26 | 2011-04-28 | Mareda Holding Bv | Chewing gum compositions comprising cannabinoids |
| WO2015131269A1 (en) | 2014-03-04 | 2015-09-11 | Pharmascience Inc. | Orally disintegrating tablet of nabilone comprising mannitol-based granules |
| US20160015683A1 (en) | 2014-07-21 | 2016-01-21 | Pharmaceutical Productions, Inc. | Solid dosage form composition for buccal or sublingual administration of cannabinoids |
| US20160220593A1 (en) | 2015-02-02 | 2016-08-04 | Axim Biotechnologies, Inc. | Cannabinoid and sugar alcohol complex, methods to make and use |
| US20170368020A1 (en) | 2016-06-22 | 2017-12-28 | Mastix, Llc | Oral compositions delivering therapeutically effective amounts of cannabinoids |
| WO2018023166A1 (en) | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| US20180221332A1 (en) | 2017-02-05 | 2018-08-09 | CannTab Therapeutics Limited | Flash-Melt Cannabinoid Formulations |
| US20180263913A1 (en) | 2017-03-16 | 2018-09-20 | CannTab Therapeutics, Limited | Modified Release Multi-Layer Tablet Cannabinoid Formulations |
| US20180289665A1 (en) | 2014-12-07 | 2018-10-11 | One World Cannabis Ltd | Use of cannabis to treat migraine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2664315C (en) * | 2006-09-15 | 2016-01-19 | Echo Pharmaceuticals B.V. | Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| EP2164462B1 (de) * | 2007-06-06 | 2017-05-31 | Basf Se | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten |
| WO2009151072A1 (ja) * | 2008-06-13 | 2009-12-17 | 大日本住友製薬株式会社 | 口腔内速崩壊錠及びその製造方法 |
| KR20130076015A (ko) * | 2011-12-28 | 2013-07-08 | 주식회사 삼양바이오팜 | 높은 경도를 갖는 속붕정 및 이의 제조 방법 |
| EP2609912A1 (en) * | 2011-12-30 | 2013-07-03 | Deva Holding Anonim Sirketi | Pharmaceutical combination of fingolimod and nabiximols |
| JP2020520966A (ja) * | 2017-05-22 | 2020-07-16 | ジービーエス グローバル バイオファーマ,インコーポレイテッド | Trpv1を標的にするミルセン及びカンナビノイド含有組成物 |
| JP2021513566A (ja) * | 2018-02-09 | 2021-05-27 | ニュートリスキ インターナショナル インク.Neutrisci International Inc. | スチルベノイドとカンナビノイドとの共結晶を含む組成物 |
-
2020
- 2020-04-17 CN CN202080029225.3A patent/CN113784704A/zh active Pending
- 2020-04-17 BR BR112021020523A patent/BR112021020523A2/pt unknown
- 2020-04-17 AU AU2020258631A patent/AU2020258631B2/en active Active
- 2020-04-17 FI FIEP20727578.5T patent/FI3920891T3/fi active
- 2020-04-17 EP EP23196168.1A patent/EP4268815A3/en active Pending
- 2020-04-17 PL PL20727578.5T patent/PL3920891T3/pl unknown
- 2020-04-17 JP JP2021561780A patent/JP7556882B2/ja active Active
- 2020-04-17 WO PCT/DK2020/050102 patent/WO2020211915A1/en not_active Ceased
- 2020-04-17 DK DK20727578.5T patent/DK3920891T3/da active
- 2020-04-17 EP EP20727578.5A patent/EP3920891B1/en active Active
- 2020-04-17 MX MX2021012712A patent/MX2021012712A/es unknown
- 2020-04-17 ES ES20727578T patent/ES2975266T3/es active Active
-
2021
- 2021-09-30 ZA ZA2021/07389A patent/ZA202107389B/en unknown
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005512943A (ja) | 2001-02-14 | 2005-05-12 | ジーダブリュー ファーマ リミテッド | 医薬製剤 |
| JP2007504207A (ja) | 2003-09-05 | 2007-03-01 | アロー・ナンバー7・リミテッド | 口腔内ドラッグ・デリバリー |
| JP2010532367A (ja) | 2007-06-29 | 2010-10-07 | マクニール−ピーピーシー・インコーポレーテツド | 2部分からなるロゼンジ剤形 |
| US20110097283A1 (en) | 2008-03-26 | 2011-04-28 | Mareda Holding Bv | Chewing gum compositions comprising cannabinoids |
| WO2015131269A1 (en) | 2014-03-04 | 2015-09-11 | Pharmascience Inc. | Orally disintegrating tablet of nabilone comprising mannitol-based granules |
| US20160015683A1 (en) | 2014-07-21 | 2016-01-21 | Pharmaceutical Productions, Inc. | Solid dosage form composition for buccal or sublingual administration of cannabinoids |
| US20180289665A1 (en) | 2014-12-07 | 2018-10-11 | One World Cannabis Ltd | Use of cannabis to treat migraine |
| US20160220593A1 (en) | 2015-02-02 | 2016-08-04 | Axim Biotechnologies, Inc. | Cannabinoid and sugar alcohol complex, methods to make and use |
| US20170368020A1 (en) | 2016-06-22 | 2017-12-28 | Mastix, Llc | Oral compositions delivering therapeutically effective amounts of cannabinoids |
| WO2018023166A1 (en) | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| US20180221332A1 (en) | 2017-02-05 | 2018-08-09 | CannTab Therapeutics Limited | Flash-Melt Cannabinoid Formulations |
| US20180263913A1 (en) | 2017-03-16 | 2018-09-20 | CannTab Therapeutics, Limited | Modified Release Multi-Layer Tablet Cannabinoid Formulations |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021012712A (es) | 2021-11-12 |
| BR112021020523A2 (pt) | 2021-12-07 |
| EP4268815A3 (en) | 2024-02-21 |
| EP3920891B1 (en) | 2024-02-21 |
| ZA202107389B (en) | 2025-04-30 |
| CN113784704A (zh) | 2021-12-10 |
| PL3920891T3 (pl) | 2024-05-20 |
| ES2975266T3 (es) | 2024-07-04 |
| EP4268815A2 (en) | 2023-11-01 |
| AU2020258631B2 (en) | 2023-11-02 |
| FI3920891T3 (fi) | 2024-03-19 |
| AU2020258631A1 (en) | 2021-10-28 |
| DK3920891T3 (da) | 2024-03-18 |
| JP2022529037A (ja) | 2022-06-16 |
| WO2020211915A1 (en) | 2020-10-22 |
| EP3920891A1 (en) | 2021-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020258631B2 (en) | Fast disintegrating cannabinoid tablets | |
| US11903919B2 (en) | Oral cannabinoid tablet | |
| CA3040513C (en) | An oral cannabinoid tablet | |
| CA3040532C (en) | Lozenge for improved delivery of cannabinoids | |
| EP3920890B1 (en) | An oral cannabinoid tablet | |
| AU2020260255B2 (en) | Cannabinoid lozenge formulation | |
| US20230218512A1 (en) | Fast Disintegrating Cannabinoid Tablets | |
| US20260108543A1 (en) | Self-Emulsifying Systems For Cannabinoids | |
| US20250261675A1 (en) | Cannabinoid Lipid Premixture | |
| CA3065042C (en) | Fast disintegrating cannabinoid tablets | |
| KR20260034661A (ko) | 칸나비노이드의 지속 방출을 위한 점착성 구강 디스크 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230414 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230414 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240304 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240311 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240610 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240819 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240912 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7556882 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |